Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Study of Osteoporotic Fractures Research Group
10.1038/s41419-020-2481-5 45
Antiinflammatory actions of glucagon-like peptide-1based therapies beyond metabolic benefits Text PDF Abstract Therapies based on glucagon-like peptide-1 (GLP-1) reduce rates of cardiovascular and chronic kidney disease in people with type 2 diabetes and/or obesity, with ongoing clinical trials investigating their effects in people with metabolic liver disease, arthritis, and both substance use and neurodegenerative disorders
Sadeghdoust M, Das A, Kaushik DK
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 20.98
US$ 25.35
US$ 23.30
US$ 28.61
US$ 27.64
US$ 25.07
US$ 29.42
